Barinthus Biotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 51.35% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
22.5%	Oxford Science Enterprises	8,797,770	€15.5m	0%	22.38%
13.3%	M&G Investment Management Limited	5,197,349	€9.2m	0%	0.02%
3.88%	GV Management Company, LLC	1,513,644	€2.7m	0%	0.23%
3.64%	HongShan	1,420,473	€2.5m	0%	0.19%
3.19%	William Enright	1,243,377	€2.2m	0%	no data
1.65%	Dean Capital Investments Management, LLC	642,204	€1.1m	0%	1.15%
1.39%	BlueCrest Capital Management Limited	542,673	€955.5k	0%	0.59%
0.43%	Robert W. Baird & Co. Incorporated, Asset Management Arm	167,705	€295.3k	-14.6%	no data
0.31%	Johns Hopkins University Endowment arm	122,237	€215.2k	13.2%	0.01%
0.28%	U.S. Global Investors, Inc.	107,914	€190.0k	0%	0.01%
0.27%	Graham Griffiths	104,209	€183.5k	0%	no data
0.12%	Robin Wright	48,256	€85.0k	0%	no data
0.071%	Renaissance Technologies LLC	27,700	€48.8k	-6.73%	no data
0.059%	Ipswich Investment Management Company, Inc.	23,075	€40.6k	0%	0.01%
0.059%	Joseph C. Scheeren	23,000	€40.5k	0%	no data
0.038%	Janney Montgomery Scott LLC, Asset Management Arm	15,008	€26.4k	0%	no data
0.033%	Morgan Stanley, Investment Banking and Brokerage Investments	12,862	€22.6k	-21.9%	no data
0.03%	Geode Capital Management, LLC	11,568	€20.4k	0%	no data
0.027%	Pierre Armand Morgon	10,506	€18.5k	0%	no data
0.0077%	Anne Phillips	3,000	€5.3k	0%	no data
0.0077%	Alex Hammacher	3,000	€5.3k	0%	no data
0.0065%	Envestnet Asset Management, Inc.	2,523	€4.4k	501%	no data
0.0044%	Karen Dawes	1,700	€3.0k	0%	no data
0.004%	UBS Asset Management AG	1,547	€2.7k	0%	no data
0.00027%	New England Capital Financial Advisors LLC	104	€185.6	0%	no data